Psilocybin and Escitalopram Show Distinct Brain Effects in Depression Treatment
June 11, 2025
A new randomized controlled trial directly compared the brain effec...
Read More
Stimulant Medication Use and Risk of Psychotic Experiences
June 5, 2025
Recent post marketing surveillance and observational studies have s...
Read More
Valbenazine in Elderly Adults with Tardive Dyskinesia
June 3, 2025
The use of antipsychotics in geriatric patients is complicated by t...
Read More
Comparative Cardiovascular Safety of ADHD Medications
May 29, 2025
Concerns about the cardiovascular safety of medications used for th...
Read More
FDA Clears First Blood Test Used In Diagnosing Alzheimer’s Disease
May 28, 2025
The FDA has approved the first blood-based test to help diagnose Al...
Read More
Molecular Pathways of Ketamine
May 27, 2025
Recent evidence shows a much richer picture of how ketamine promote...
Read More
Efficacy and Safety of Brexpiprazole in Adolescents with Schizophrenia
May 25, 2025
A recent study evaluated the short-term efficacy and safety of brex...
Read More
High Rates of Comorbid Depression, Anxiety in Chronic Pain
May 23, 2025
A sweeping new study reveals that nearly two in five adults living ...
Read More
Magnetic Stimulation to the Precuneus Shows Benefit in Alzheimer’s Patients
May 21, 2025
A recent study offers compelling clinical insights into the potenti...
Read More
Trial Results of Solriamfetol in MDD With/Without Excessive Daytime Sleepiness
May 18, 2025
A new phase 3 proof-of-concept trial offers early evidence that sol...
Read More
Postpartum Hormonal Contraceptive Use and Risk of Depression
May 16, 2025
Postpartum depression is a leading cause of maternal morbidity, aff...
Read More
NEI Spring Congress Highlights: Navigating Dissociative Disorders
May 8, 2025
Dr. Thomas Schwartz explored the complexities of dissociative disor...
Read More